Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Claim CE Credits
For Industry
Why Exhibit
Reserve a Booth
Exhibitor Resources
Attend
Register Now
AASLD Foundation
AASLD Members
Exhibit Hall
First Time Attendee
Mobile App & TLMdX
Networking Events
Venue & Housing
Your Safety
Program
Abstract & Program Guides
CE Credits
Global Programming
Satellite Symposia
Schedule
Speakers
TLM Theaters
Register Now
Novel Therapies and Monitoring in Cholestatic Disease
Nov
10
2025
Convention Center: Room 145, Level 1
2:00 PM - 3:30 PM
World Class Speakers
Moderator
Gideon M Hirschfield, FRCP, PhD
Toronto General Hospital
Moderator
Maria Serena Longhi, MD, PhD
Beth Israel Deaconess Medical Center
Description
This abstract parallel session features a series of reports on the exploration of new agents in AIH and PBC, along with intriguing data on enhanced monitoring in cholestatic disorders.
Journey Maps
Cholestatic and Autoimmune
Objectives
Describe the complexities and options for AIH treatments.
Discuss the potential roles for PPAR modulation in PBC.
Identify the potential roles for IBAT targeting in cholestasis.